You are here: Industry Insights > Ajinomoto Bio-Pharma

News List

Ajinomoto Bio-Pharma and Revance Therapeutics Partner contractpharma
December 23, 2020
Ajinomoto Bio-Pharma Services and Revance Therapeutics Inc. have signed a strategic commercial manufacturing agreement for the supply of DaxibotulinumtoxinA for Injection.
Ajinomoto Bio-Pharma expands small molecule manufacturing capabilities in India expresspharma
August 14, 2020
Ajinomoto Bio-Pharma Services announced expansion of small molecule manufacturing capabilities with the addition of a new production facility in Visakhapatnam, India.
Ajinomoto Bio-Pharma Introduces AJILITY Fast Track Platform for Drug Product Manufacturing americanpharmaceuticalreview
July 01, 2020
Ajinomoto Bio-Pharma Services has announced the launch of AJILITY™, a flexible and agile drug product manufacturing platform, designed to advance vaccines and therapies to market by minimizing time to production.
Trio Pharmaceuticals, Ajinomoto Bio-Pharma Announce Antibody Therapeutic Collaboration americanpharmaceuticalreview
May 04, 2020
Trio Pharmaceuticals and Ajinomoto Bio-Pharma Services announced a development collaboration agreement to evaluate AJICAP™.
Ajinomoto Bio-Pharma Services Announces Formation of External Advisory Board americanpharmaceuticalreview
March 13, 2020
Ajinomoto Bio-Pharma announced the formation of its External Advisory Board (EAB) to provide insight into industry trends and high-level advice to the Company’s leadership team.
Ajinomoto Bio-Pharma buys Indian API plant biospectrumasia
September 03, 2019
Ajinomoto Bio-Pharma Services Acquires Remaining Interest in Granules OmniChem Joint Venture in India
Belgium's Ajinomoto Bio-Pharma buys Indian API plant biospectrumasia
August 31, 2019
Conclusion of this transaction is subject to fulfillment of certain closing conditions and customary government approvals. Closing is expected to be completed during fourth quarter 2019.
GeneDesign joins Ajinomoto Bio-pharma biospectrumasia
April 09, 2019
In addition, on April 5th, the company celebrated the grand opening of an approximately 2000 m2 building, expanding oligonucleotide synthesis and supply capabilities (µg to 10 kg) to support customer needs.
Ajinomoto Bio-Pharma services announces its assets expansion biospectrumasia
March 13, 2019
Aji Bio-Pharma is also adding a new fully isolated, nested flexible fill line, installing automated packaging and labeling equipment, and upgrading its continuous flow and small molecule API manufacturing capabilities
Ajinomoto Bio-Pharma Services Expands contractpharma
March 13, 2019
Ajinomoto Bio-Pharma Services, a global provider of bio-pharmaceutical contract development and manufacturing, is expanding its capabilities and capacities.